相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Engineered Soluble Monomeric IgG1 CH3 Domain GENERATION, MECHANISMS OF FUNCTION, AND IMPLICATIONS FOR DESIGN OF BIOLOGICAL THERAPEUTICS
Tianlei Ying et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties
Thomas Tiller et al.
MABS (2013)
Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression
Andrew Buchanan et al.
MABS (2013)
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
Aran F. Labrijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Rapid prediction of expression and refolding yields using phage display
Kip Dudgeon et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress
Takahiko Ito et al.
PROTEIN SCIENCE (2013)
Toward aggregation-resistant antibodies by design
Christine C. Lee et al.
TRENDS IN BIOTECHNOLOGY (2013)
Shark Variable New Antigen Receptor (VNAR) Single Domain Antibody Fragments: Stability and Diagnostic Applications
Katherine Griffiths et al.
ANTIBODIES (2013)
Engineering an Improved IgG4 Molecule with Reduced Disulfide Bond Heterogeneity and Increased Fab Domain Thermal Stability
Shirley J. Peters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Engineering Aggregation Resistance in IgG by Two Independent Mechanisms: Lessons from Comparison of Pichia pastoris and Mammalian Cell Expression
Jonas V. Schaefer et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Stabilisation of the Fc Fragment of Human IgG1 by Engineered Intradomain Disulfide Bonds
Gordana Wozniak-Knopp et al.
PLOS ONE (2012)
General strategy for the generation of human antibody variable domains with increased aggregation resistance
Kip Dudgeon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Transfer of engineered biophysical properties between different antibody formats and expression systems
Jonas V. Schaefer et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Disulfide linkage engineering for improving biophysical properties of human VH domains
Dae Young Kim et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions
Joseph M. Perchiacca et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Shortened Engineered Human Antibody CH2 Domains INCREASED STABILITY AND BINDING TO THE HUMAN NEONATAL Fc RECEPTOR
Rui Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability
Greg Hussack et al.
PLOS ONE (2011)
Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions
Joseph M. Perchiacca et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Acid-Induced Aggregation of Human Monoclonal IgG1 and IgG2: Molecular Mechanism and the Effect of Solution Composition
Sanjay B. Hari et al.
BIOCHEMISTRY (2010)
Expression, purification and characterization of recombinant interleukin-21
Carol M. Y. Lee et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Development trends for human monoclonal antibody therapeutics
Aaron L. Nelson et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates
Heather Franey et al.
PROTEIN SCIENCE (2010)
Formulation and manufacturability of biologics
Steven J. Shire
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Engineered Human Antibody Constant Domains with Increased Stability
Rui Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Aggregation-Prone Motifs in Human Immunoglobulin G
Naresh Chennamsetty et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Surface Activity of a Monoclonal Antibody
Hanns-Christian Mahler et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Potential aggregation prone regions in biotherapeutics A survey of commercial monoclonal antibodies
Xiaoling Wang et al.
MABS (2009)
Design of therapeutic proteins with enhanced stability
Naresh Chennamsetty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points
M. Arbabi-Ghahroudi et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Sequence determinants of protein aggregation in human VH domains
Kip Dudgeon et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Free sulfhydryl measurement as an indicator of antibody stability
Eilyn R. Lacy et al.
ANALYTICAL BIOCHEMISTRY (2008)
Human IgG2 antibodies display disulfide-mediated structural isoforms
Jette Wypych et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Thermodynamically stable aggregation-resistant antibody domains through directed evolution
Kristoffer Famm et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains
Pierre A. Barthelemy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Biotechnology applications of amino acids in protein purification and formulations
T. Arakawa et al.
AMINO ACIDS (2007)
Repertoires of aggregation-resistant human antibody domains
Daniel Christ et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2007)
A broad range of Fab stabilities within a host of therapeutic IgGs
Ellen Garber et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Selection of human antibody fragments by phage display
Carol M. Y. Lee et al.
NATURE PROTOCOLS (2007)
Structure-based stability engineering of the mouse IgG1 Fab fragment by modifying constant domains
Tuija Teerinen et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Formulation and delivery issues for monoclonal antibody therapeutics
Ann L. Daugherty et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
The importance of sequence diversity in the aggregation and evolution of proteins
CF Wright et al.
NATURE (2005)
Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences
GG Tartaglia et al.
PROTEIN SCIENCE (2005)
Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure
S Sambashivan et al.
NATURE (2005)
Prediction of aggregation-prone and aggregation-susceptible regions in proteins associated with neurodegenerative diseases
AP Pawar et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Protein aggregation and its inhibition in biopharmaceutics
W Wang
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Crystal structure of HEL4, a soluble, refoldable Human VH single domain with a germ-line scaffold
L Jespers et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Optimization of the antibody CH3 domain by residue frequency analysis of IgG sequences
SJ Demarest et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
AM Fernandez-Escamilla et al.
NATURE BIOTECHNOLOGY (2004)
Aggregation-resistant domain antibodies selected on phage by heat denaturation
L Jespers et al.
NATURE BIOTECHNOLOGY (2004)
Recombinant protein folding and misfolding in Escherichia coli
F Baneyx et al.
NATURE BIOTECHNOLOGY (2004)
Detection and prevention of protein aggregation before, during, and after purification
SE Bondos et al.
ANALYTICAL BIOCHEMISTRY (2003)
Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach
S Ewert et al.
BIOCHEMISTRY (2003)
Designed to be stable:: Crystal structure of a consensus ankyrin repeat protein
A Kohl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Biophysical properties of human antibody variable domains
S Ewert et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface
W Vranken et al.
BIOCHEMISTRY (2002)
Biophysical properties of camelid VHH domains compared to those of human VH3 domains
S Ewert et al.
BIOCHEMISTRY (2002)
Optimal design features of camelized human single-domain antibody libraries
J Tanha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Stability engineering of antibody single-chain Fv fragments
A Wörn et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Native protein sequences are close to optimal for their structures
B Kuhlman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides
A Knappik et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1β
JM Finke et al.
BIOCHEMISTRY (2000)
分享论文
